Fount Bio announces Dan Browne, MBA to join Board of Directors.

Fount Bio, Inc. is pleased to announce the appointment of Dan Browne as an independent Director to Fount Bio’s Board of Directors. Dan joins current board members Anthony Aiudi and Justin Burns from Morningside Ventures and co-founders Samir Mitragotri and Douglas Levinson. Dan Browne has more than 30 years of ...
Learn more

Fount Bio closes Series A financing led by Morningside Ventures to advance Flī-HA platform technology to clinical proof of concept.

Fount Bio, Inc. successfully closed a Series A round of financing led by Morningside Ventures. This initial investment will be focused on progressing Fount Bio’s, Flī-HA (functional ligand hyaluronic acid) technology forward into clinical evaluation for aesthetic and dermatological indications. Anthony Aiudi and Justin Burns from Morningside Ventures will be ...
Learn more